Literature DB >> 20046676

Preservation of stem cells.

Jacob Hanna1, Allison Hubel.   

Abstract

Adult stem cells (hematopoietic and mesenchymal) have demonstrated tremendous human therapeutic potential. Currently, human embryonic stem cells are used principally for understanding development and disease progression but also hold tremendous therapeutic potential. The ability to preserve stem cells is critical for their use in clinical and research applications. Preservation of cells permits the transportation of cells between sites, as well as completion of safety and quality control testing. Preservation also permits the development of a 'manufacturing paradigm' for cell therapies, thereby maximizing the number of products that can be produced at a given facility. in this article, we will review modes of preservation and the current status of preservation of hematopoietic, mesenchymal and human embryonic stem cells. Current and emerging issues in the area of stem cell preservation will also be described.

Entities:  

Keywords:  cell therapy; cryopreservation; preservation; stabilization; stem cells

Year:  2009        PMID: 20046676      PMCID: PMC2781093          DOI: 10.4161/org.5.3.9585

Source DB:  PubMed          Journal:  Organogenesis        ISSN: 1547-6278            Impact factor:   2.500


  47 in total

1.  Efficacy of the anticaspase agent zVAD-fmk on post-thaw viability of canine spermatozoa.

Authors:  Augustine T Peter; Catharina Linde-Forsberg
Journal:  Theriogenology       Date:  2003-04-01       Impact factor: 2.740

Review 2.  Bone marrow stem cell transplantation for cardiac repair.

Authors:  Husnain Kh Haider; Muhammad Ashraf
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-06       Impact factor: 4.733

Review 3.  Cryopreservation of hematopoietic stem cells.

Authors:  David Berz; Elise M McCormack; Eric S Winer; Gerald A Colvin; Peter J Quesenberry
Journal:  Am J Hematol       Date:  2007-06       Impact factor: 10.047

4.  Evaluation of bone marrow mesenchymal stem cell standard cryopreservation procedure efficiency.

Authors:  K A T Carvalho; C C Cury; L Oliveira; R I I Cattaned; M Malvezzi; J C Francisco; A Pachalok; M Olandoski; J R Faria-Neto; L C Guarita-Souza
Journal:  Transplant Proc       Date:  2008-04       Impact factor: 1.066

5.  Sugars exert a major influence on the vitrification properties of ethylene glycol-based solutions and have low toxicity to embryos and oocytes.

Authors:  L L Kuleshova; D R MacFarlane; A O Trounson; J M Shaw
Journal:  Cryobiology       Date:  1999-03       Impact factor: 2.487

6.  Caspase inhibition reduces apoptotic death of cryopreserved porcine hepatocytes.

Authors:  T Yagi; J A Hardin; Y M Valenzuela; H Miyoshi; G J Gores; S L Nyberg
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

7.  Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure.

Authors:  R Zenhäusern; A Tobler; L Leoncini; O M Hess; P Ferrari
Journal:  Ann Hematol       Date:  2000-09       Impact factor: 3.673

8.  Cryopreservation of human hematopoietic cells with membrane stabilizers and bioantioxidants as additives in the conventional freezing medium.

Authors:  L S Limaye; V P Kale
Journal:  J Hematother Stem Cell Res       Date:  2001-10

Review 9.  Bone marrow transplantation: a new strategy for intractable diseases.

Authors:  Susumu Ikehara
Journal:  Drugs Today (Barc)       Date:  2002-02       Impact factor: 2.245

10.  Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia.

Authors:  Robert Iannone; James F Casella; Ephraim J Fuchs; Allen R Chen; Richard J Jones; Ann Woolfrey; Michael Amylon; Keith M Sullivan; Rainer F Storb; Mark C Walters
Journal:  Biol Blood Marrow Transplant       Date:  2003-08       Impact factor: 5.742

View more
  8 in total

1.  Human Wharton's jelly stem cell conditioned medium enhances freeze-thaw survival and expansion of cryopreserved CD34+ cells.

Authors:  Hao Daniel Lin; Ariff Bongso; Kalamegam Gauthaman; Arijit Biswas; Mahesh Choolani; Chui-Yee Fong
Journal:  Stem Cell Rev Rep       Date:  2013-04       Impact factor: 5.739

Review 2.  Preserving human cells for regenerative, reproductive, and transfusion medicine.

Authors:  Waseem Asghar; Rami El Assal; Hadi Shafiee; Raymond M Anchan; Utkan Demirci
Journal:  Biotechnol J       Date:  2014-07       Impact factor: 4.677

3.  Synergistic Development of Biochips and Cell Preservation Methodologies: A Tale of Converging Technologies.

Authors:  Shangping Wang; Gloria D Elliott
Journal:  Curr Stem Cell Rep       Date:  2017-01-21

4.  Transporting Cells in Semi-Solid Gel Condition and at Ambient Temperature.

Authors:  Junjian Wang; Peng Chen; Jianzhen Xu; June X Zou; Haibin Wang; Hong-Wu Chen
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

5.  Pericardial application as a new route for implanting stem-cell cardiospheres to treat myocardial infarction.

Authors:  Jianhua Zhang; Zheng Wu; Zepei Fan; Zixi Qin; Yingwei Wang; Jiayuan Chen; Maoxiong Wu; Yangxin Chen; Changhao Wu; Jingfeng Wang
Journal:  J Physiol       Date:  2018-05-07       Impact factor: 5.182

6.  Clinically relevant preservation conditions for mesenchymal stem/stromal cells derived from perinatal and adult tissue sources.

Authors:  Anh T L Ngo; Hang M Le; Nhung T H Trinh; Adriel Peng Guo Jun; Trung Q Bach; Hue T H Bui; Van T Hoang; Anh V Bui; Liem T Nguyen; Duc M Hoang
Journal:  J Cell Mol Med       Date:  2021-10-27       Impact factor: 5.310

Review 7.  Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices.

Authors:  Ratti Ram Sharma; Kathryn Pollock; Allison Hubel; David McKenna
Journal:  Transfusion       Date:  2013-10-16       Impact factor: 3.157

Review 8.  Using Stem Cells to Grow Artificial Tissue for Peripheral Nerve Repair.

Authors:  Kulraj Singh Bhangra; Francesca Busuttil; James B Phillips; Ahad A Rahim
Journal:  Stem Cells Int       Date:  2016-04-26       Impact factor: 5.443

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.